文献速递气道管理小儿麻醉

儿童和婴儿气管插管时避免使用神经肌肉阻滞剂与使用神经肌肉阻滞剂的效果:系统综述、Meta分析和试验序贯分析

Effects of avoidance versus use of neuromuscular blocking agents for facilitation of tracheal intubation in children and infants: A systematic review with meta-analysis and trial sequential analysis.
PubMed 文献 · Eur J Anaesthesiol · 2026-02-02

该系统综述与Meta分析纳入47项随机对照试验共2276例患儿,评估避免使用神经肌肉阻滞剂(NMBA)与使用NMBA对气管插管困难发生率的影响。结果显示避免使用NMBA与困难气管插管风险增加相关(RR 3.47,95%CI 2.52-4.77,P<0.001,I²=18%,中等确定性证据),试验序贯分析调整后RR为3.68(95%CI 2.22-6.11)。两组严重不良事件风险无显著差异(极低确定性证据)。

要点

  • 证据确定性中等,试验序贯分析结果稳健
  • 严重不良事件风险两组无显著差异,但证据确定性极低

核心结论

  • 在儿童和婴儿中,与避免使用NMBA相比,使用NMBA促进气管插管可降低困难气管插管的发生率。

研究设计与样本

  • 系统综述与Meta分析,纳入47项随机对照试验,共2276例患儿,其中3项试验被评为低偏倚风险。
  • 检索截至2025年7月8日,涵盖MEDLINE、EMBASE、CENTRAL、BIOSIS、Web of Science、Advanced Google和CINAHL等数据库及试验注册库。

主要发现

  • 试验序贯分析显示避免使用NMBA的α消耗调整后RR为3.68(95%CI 2.22-6.11;α=5%,β=90%)。
  • 避免使用NMBA与使用NMBA相比,严重不良事件风险无显著增加(极低确定性证据)。

关键数值与推荐

  • 纳入标准:接受经口或经鼻气管插管(直接喉镜或视频喉镜)的儿科患者,插管时使用或不使用NMBA,适用于任何需要全身麻醉的操作。
  • 主要结局为困难气管插管的发生率。

临床怎么用

  • 在儿童和婴儿气管插管时,使用NMBA可降低困难插管的风险,应作为常规考虑。
  • 需权衡使用NMBA的获益与潜在风险,尤其关注严重不良事件(证据确定性极低)。

局限性

  • 仅3项试验被评为低偏倚风险,整体研究质量可能受限。
  • 严重不良事件结局的证据确定性极低,需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Use of neuromuscular blocking agents (NMBAs) is recommended by European Society of Anaesthesiology and Intensive Care in neonates (<1 month) and infants (<1 year) to facilitate tracheal intubation, but the use in other paediatric age groups is still debated. OBJECTIVE: We assessed the effects of avoidance versus use of NMBA for facilitation of tracheal intubation in children and infants. The primary outcome was incidence of difficult tracheal intubation. DESIGN: A systematic review of randomised controlled trials with meta-analyses and trial sequential analysis. ELIGIBILITY CRITERIA: Paediatric patients undergoing tracheal intubation (oral or nasal) using direct laryngoscopy or video laryngoscopy with or without NMBAs for any type of procedure requiring general anaesthesia. DATA SOURCES: A systematic search up to 8 July 2025 in Medical Literature Analysis and Retrieval System Online ( MEDLINE), Excerpta Medica Database (EMBASE), the Cochrane Central Register of Controlled Trials (CENTRAL), BioSciences Information Service of Biological Abstracts (BIOSIS), International Web of Science and Advanced Google and Cumulative Index to Nursing & Allied Health Literature (CINAHL). Trial registries were explored to uncover unpublished data or supplementary trials, http://links.lww.com/EJA/B253 . RESULTS: We identified 47 randomised clinical trials ( n = 2276). Three trials were categorised as 'low risk of bias'. Thirty trials reported the primary outcome. Avoidance of NMBAs was associated with increased risk of difficult tracheal intubation with a risk ratio (RR) of 3.47 [95% confidence interval (CI), 2.52 to 4.77, P < 0.001, I2 = 18%] and moderate certainty of evidence. The trial sequential analysis resulted in α -spending adjusted RR of 3.68 when avoiding NMBAs (95% CI, 2.22 to 6.11; α = 5%, β = 90%). We found no significant increased risk of serious adverse events comparing avoidance and use of NMBA (very low certainty of evidence). CONCLUSION: Using NMBAs for facilitation of tracheal intubation reduces the incidence of difficult tracheal intubation compared to avoidance of NMBA in children and infants.

来源:Eur J Anaesthesiol,查看原文。版权归原作者所有。

引用

  1. Christensen MI, Creutzburg A, Vested M, et al. Effects of avoidance versus use of neuromuscular blocking agents for facilitation of tracheal intubation in children and infants: A systematic review with meta-analysis and trial sequential analysis. Eur J Anaesthesiol. 2026. PMID: 41630605. doi:10.1097/EJA.0000000000002358

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。